Search Results

Impact of PD-1 and PD-L1 Expression on Overall Survival in Patients With NSCLC and Melanoma.

• Authors : Khudari, Amin Zakkour; Harutunyan, Tammy; Khadari, Mohamad Zakour

Subjects: NON-small-cell lung carcinoma; PROTEIN expression; MELANOMA

• Source: Pharmacy Practice in Focus: Oncology. Aug2024, Vol. 6 Issue 6, p8-12. 5p.

Record details

Borneol-modified docetaxel plus tetrandrine micelles for treatment of drug-resistant brain glioma.

• Authors : Liu, Yang (AUTHOR); Cai, Jia-yu (AUTHOR); Zhang, Lu (AUTHOR)

Subjects: DOCETAXEL; BLOOD-brain barrier; DRUG resistance in cancer cells

• Source: Drug Development & Industrial Pharmacy. Feb2024, Vol. 50 Issue 2, p135-149. 15p.

Record details

Investigating Mechanisms and Causes Related to Angiogenesis: A Review.

• Authors : Davidescu, Lavinia; Precup, Alexandru Iosif; Fodor, Radu

Subjects: DRUG resistance in cancer cells; NEOVASCULARIZATION; PAROXYSMAL hemoglobinuria

• Source: Archives of Pharmacy Practice. Jan-Mar2024, Vol. 15 Issue 1, p47-52. 6p.

Record details

The effects of umbilical cord-derived macrophage exosomes loaded with cisplatin on the growth and drug resistance of ovarian cancer cells.

• Authors : Zhang, Xiaohui (AUTHOR); Liu, Li (AUTHOR); Tang, Meiling (AUTHOR)

Subjects: DRUG resistance in cancer cells; EXOSOMES; CORD blood

• Source: Drug Development & Industrial Pharmacy. Jul2020, Vol. 46 Issue 7, p1150-1162. 13p.

Record details

Co-administration of paclitaxel and 2-methoxyestradiol using folate-conjugated human serum albumin nanoparticles for improving drug resistance and antitumor efficacy.

• Authors : Liu, Xinyang (AUTHOR); Zhao, Taoqian (AUTHOR); Xu, Yue (AUTHOR)

Subjects: DRUG resistance in cancer cells; NANOPARTICLES; MULTIDRUG resistance

• Source: Pharmaceutical Development & Technology. Jan2021, Vol. 26 Issue 1, p1-10. 10p.

Record details

Verastem Begins Submission for Ovarian Cancer Combination.

Subjects: THERAPEUTIC use of antineoplastic agents; CANCER relapse; DRUG resistance in cancer cells

• Source: Formulary Watch. 5/24/2024, p1-1. 1p. 1 Color Photograph.

Record details

FDA Grants Priority Review for Second Epkinly Indication.

Subjects: PHARMACEUTICAL industry & economics; THERAPEUTIC use of monoclonal antibodies; THERAPEUTIC use of antineoplastic agents

• Source: Formulary Watch. 2/28/2024, p1-1. 1p. 1 Color Photograph.

Record details

Proteomic investigation of resistance to chemotherapy drugs in osteosarcoma.

• Authors : Zhang, Shuang; Qin, Yu-Ping; Kuang, Jiang-Ming

Subjects: OSTEOSARCOMA; CANCER chemotherapy; ANTINEOPLASTIC agents

• Source: Technology & Health Care. 2018, Vol. 26 Issue 1, p145-153. 9p.

Record details

FDA Grants Accelerated Approval of Novel Ovarian Cancer Therapy.

Subjects: THERAPEUTIC use of monoclonal antibodies; THERAPEUTIC use of antineoplastic agents; DRUG approval

• Source: Formulary Watch. 11/15/2022, p1-2. 2p.

Record details

FDA Grants Accelerated Approval to Elrexfio for Multiple Myeloma.

Subjects: THERAPEUTIC use of monoclonal antibodies; THERAPEUTIC use of antineoplastic agents; DRUG approval

• Source: Formulary Watch. 8/15/2023, p1-1. 1p.

Record details